These results suggest that AFP464-sensitive breast cancer cell lines, regardless of ER status, have constitutive cytoplasmic expression of AhR, whereas AFP464-resistant cell lines have undetectable or predominantly nuclear AhR protein expression. The gene discussed is AHR; the disease is breast carcinoma.